Cambridge Healthtech Institute’s 6th Annual

Rational Combination Cancer Immunotherapy

August 27-28, 2018

As the discovery of new cancer immunotherapies continues to grow, developers are identifying promising patient-specific neo-antigens and finding new ways to modulate the immune response beyond or in combination with checkpoint inhibitors. Numerous clinical studies are exploring the application of these therapeutics in combinations with traditional and experimental agents. Thus, emerging data from these preclinical models and clinical trials demonstrate the need for massive data analytics to provide actionable answers for patients. CHI’s 6th Annual Rational Combination Cancer Immunotherapy conference takes a forward-looking perspective on the design of drug products and treatment progressions and builds on the knowledge arising from these exploratory trials.    

The meeting will cover a range of combinatorial and computational topics including, but not limited to:


  • Molecular biology of tumor microenvironment and immune checkpoint pathways
  • Novel and emerging tumor antigens for targeting

Cancer Immunotherapy Strategies

  • Next-generation checkpoint inhibitors
  • Emerging therapeutic strategies
    • T regulatory cells, antigen-presenting cells, myeloid suppressor cells
  • Combination therapies
    • Checkpoint inhibitor combinations
    • Agonist-checkpoint combination studies
    • Emerging combination strategies             
  • Preclinical studies of novel immuno-modulatory agents
  • Updates on clinical studies

Immunomonitoring and Predictive Markers

  • Predictive preclinical models
  • Technological innovations enabling immunomonitoring

Managing Big Data

  • Database centralization
  • Standardization
  • Analytics

If you would like to submit a proposal to give a presentation at this meeting, please click here.

The deadline for priority consideration is February 9, 2018.

All proposals are subject to review by session chairmen and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For more details on the conference, please contact:
Mary Ann Brown
Executive Director, Conferences
Cambridge Healthtech Institute
Phone: (+1) 781-972-5497

For partnering and sponsorship information, please contact:
Rod Eymael
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-247-6286